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Classical anaerobic infections are so-called exogenous
infections such as gas gangrene caused by Clostridium
(Clostridium perfringens, etc.), tetanus due to C. tetani and
botulism due to C. botulinum. Anaerobes are a component
of the indigenous ﬂora of the human skin, digestive tract
and urogenital system. The density of bacteria found in the
large intestine is 1,000 times and that in the oral cavity 10
times higher for anaerobes than for aerobes. About 100
types of anaerobes are isolated from clinical samples. Of
all anaerobes isolated in laboratories, a third belong to the
Bacteroides fragilis group (B. fragilis, B. thetaiotaomicron,
B. distasonis, etc.), another third to the anaerobic gram-
positive cocci such as genus Peptostreptococcus and the
remainder are Prevotella, Fusobacterium, Clostridium and
non-spore-forming gram-positive rods. These bacteria can
be isolated from all parts of the body and can be respon-
sible for various endogenous infections such as brain
abscess and diabetic foot gangrene. Bacteria of genus
Actinomyces and Propionibacterium are relatively resistant
to oxygen and can induce skin and oral infections. Bacteria
of genus Bacteroides and Clostridium can also survive
oxygen-rich environments and cause soft tissue infections
of usually aseptic areas in the vicinity of the digestive tract
or in areas below the waist. Bacteria of genus Fusobacte-
rium, Prevotella and Porphyromonas are also isolated from
patients with head/neck including mouth or gastrointestinal
infections, but they are susceptible to oxygen and die
within 10–30 min if exposed to air.
Regarding the care needed when dealing with anaerobic
infections which have developed in patients with underly-
ing diseases or complications, we can say that special care
is needed not only for prevention of infections in general
but also for prevention of anaerobic infections in patients
who are more likely than usual to develop such infections
(e.g., patients with diabetes mellitus, malignant tumors or
malignant hematological diseases, those receiving steroid
therapy, and immunosuppressed patients). Because a high
density of anaerobes is found in the indigenous ﬂora,
infection with a mixture of anaerobes and aerobes (patho-
gens for endogenous infection) can be more severe in these
compromised hosts. Conditions characterized by a close
association between anaerobic infection and a compro-
mised host status are skin/soft tissue infections (foot gan-
grene, etc.) in diabetic patients and bacteremia/sepsis in
patients with malignant tumors or hematopoietic diseases.
From patients with diabetic foot gangrene, not only genus
Staphylococcus but also anaerobic gram-positive cocci
such as Finegoldia magna are often isolated. Gram-nega-
tive rods of genus Bacteroides and Prevotella are also
isolated. In patients with malignant gastrointestinal
tumors, bacteria of genus Clostridium such as C. septicum,
C. perfringens, C. clostridioforme and C. symbiosum are
sometimes isolated independently or in combination with a
low density of some other bacteria from blood culture. In
patients with hematopoietic diseases (neutropenia, mye-
logenous leukemia, etc.), blood culture sometimes reveals
Leptotorichia buccalis or Sneathia sanguinegens which are
simply indigenous bacteria in healthy individuals. In
addition, bacteria of genus Fusobacterium may be isolated.
Many anaerobic infections generally involve multiple
pathogenic bacteria. Surgical drainage, necrotic tissue
removal and selection of antibiotics effective against both
aerobes and anaerobes are essential for treatment. Because
anaerobes grow slowly and take considerable time for
culture, the time required until sensitivity test results are
obtained is long, often forcing physicians to begin empir-
ical treatment before such results become available. Anti-
bacterial agents often selected for the treatment of
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anaerobic infections are broad-spectrum agents. These
include sulbactam/ampicillin, cefoxitin, imipenem/cila-
statin and tazobactam/piperacillin. Chloramphenicol is
effective against many anaerobes even at present, but it is
seldom used nowadays because of serious adverse effects.
Clindamycin is also used to deal with anaerobic infections,
but, because of the resistance of some strains of the
B. fragilis group, this drug has been increasingly replaced
with other antibacterial agents, resulting in a decrease in
the amount of this drug used. Metronidazole is not indi-
cated for anaerobic infections in Japan, but this drug
has excellent activity against anaerobes in general. When
metronidazole is applied in an off-label fashion, care is
needed because this drug exerts an antabuse-like action and
adverse reactions such as central nervous system disorders
can be induced by prolonged use or high-dose adminis-
tration for non-indicated cases (i.e., use involving non-
authorized methods or dose levels). In patients with
uncompensated liver disease, the half-life of this drug is
longer than usual, thus necessitating adjustment of the dose
level. When other drugs are used as well, care is usually
needed when administering the medication, with the fea-
tures of individual patients (underlying diseases and com-
plications) being taken into account.
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